Related Experiment Video
Updated: Jun 13, 2026

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
Published on: January 12, 2020
[Regulation and mechanism of Notch signaling pathway in small cell lung cancer]
Xiu-ming Zhang1, Jie-xin Wang, Xiao-guang Lei
1Department of Pathology, the First Affiliated Hospital, Zhejiang University, Hangzhou, China.
Objective:
To investigate the status of Notch signaling pathway in small cell lung cancer (SCLC).
Methods:
Expression plasmids of pEFBOS-NIC-MYC and pEFBOS-neo were transfected into NCI-H446 cells. Stably transfected cell lines were selected and their growth rates were examined by MTT method. Expression of downstream genes along the Notch signaling pathway were studied by RT-PCR. Protein expression of euroendocrine markers of CgA and NSE were detected by Western blot analysis and immunocytochemistry.
Results:
The expression of HES1 was increased in the pEFBOS-NIC-MYC group, but the expression of hASH in the pEFBOS-NIC-MYC group was decreased significantly. The transfected cells with pEFBOS-NIC-MYC plasmid showed a significantly slower growth rate compared with that of two control groups (P < 0.05, Student's t-test). Immunocytochemistry of NSE showed that PUs in the NIC transfected group, sham group and negative control group were 7.21 ± 0.59, 28.25 ± 1.46, 30.57 ± 1.31 respectively, the former one was smaller than the values of the latter two significantly (P < 0.01). Western blot analysis showed the grave scales of CgA in NIC transfected group and sham group to be 0.54 ± 0.03 and 0.99 ± 0.05 respectively (grave scales of the negative control was set as 1.00), the former one significantly smaller than that of the other two groups (P < 0.01). The grave scales of NSE in the NIC transfected group and sham group were 0.43 ± 0.02 and 1.07 ± 0.09 respectively (grave scales of the negative control was set as 1.00) and the former one was significantly smaller than the other two groups (P < 0.01).
Conclusion:
Notch signaling pathway regulates SCLC cells through its inhibitory effect on hASH1 transcription via HES1 along with an expression inhibition of neuroendocrine markers in SCLC.
Insights
The Notch signaling pathway inhibits small cell lung cancer (SCLC) cell growth by decreasing neuroendocrine markers. This pathway regulates SCLC through HES1, affecting hASH1 transcription and neuroendocrine differentiation.
Area of Science:
- Oncology
- Molecular Biology
- Cell Signaling
Background:
- Small cell lung cancer (SCLC) is an aggressive form of lung cancer with limited treatment options.
- The Notch signaling pathway plays a crucial role in cell differentiation and proliferation.
- Dysregulation of Notch signaling has been implicated in various cancers, including SCLC.
Purpose of the Study:
- To investigate the role and status of the Notch signaling pathway in SCLC.
- To determine how Notch signaling affects SCLC cell growth and neuroendocrine differentiation.
Main Methods:
- Transfection of NCI-H446 SCLC cells with Notch pathway components (NIC).
- Assessment of cell growth rates using the MTT assay.
- Analysis of Notch downstream gene expression (HES1, hASH1) via RT-PCR.
- Evaluation of neuroendocrine marker expression (CgA, NSE) using Western blot and immunocytochemistry.
Main Results:
- Overexpression of NIC in SCLC cells led to increased HES1 and decreased hASH1 expression.
- NIC-transfected cells exhibited significantly slower growth rates compared to controls.
- Expression of neuroendocrine markers CgA and NSE was significantly reduced in NIC-transfected cells.
Conclusions:
- The Notch signaling pathway inhibits SCLC cell proliferation and neuroendocrine differentiation.
- HES1 acts as a mediator, suppressing hASH1 transcription and neuroendocrine marker expression in SCLC.
Related Concept Videos
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Non-Canonical Wnt Signaling Pathways
Non-Canonical Wnt Signaling Pathways
Canonical Wnt Signaling Pathway

